CTRI/2009/091/000786已完成3 期
A randomized, open label, comparative study to evaluate the efficacy and safety of Recombinant Human Erythropoietin therapy in management of anemia in patients suffering from Chronic Renal Failure.
upin Limited India0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion Criteria:
- •Patients of in the age group of 20-60 years
- •Patients with
- •ï??Haemoglobin < 10.0 gm/dl
- •ï??Hematocrit < 30 vol. %
排除标准
- •Exclusion Criteria:
- •Patients suffering from superimposed uncontrolled infection or other active infection
- •Patient suffering from malignancy of bone marrow (leukemia)
研究者
相似试验
进行中（未招募）
1 期
Dermatitis StudyEUCTR2017-001574-42-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd123
已完成
3 期
A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 µg ethinyl estradiol (EE).NL-OMON29993Organon Nederland BV48
进行中（未招募）
1 期
A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 µg ethinyl estradiol (EE).EUCTR2006-001546-14-NLV Organon48
尚未招募
3 期
An open label, prospective comparative study to evaluate the proposed therapy in adults with mild symptomatic COVID-19 patients receiving the standard treatment of COVID infection.CTRI/2020/09/027944Public Health Department
尚未招募
2 期
A study to evaluate the efficacy of Bharangyadi Madhuka and Talishadi Churna in the management of Tamaka Shwas(Bronchial Asthma)CTRI/2024/07/071146Institute For Ayurved Studies and Research